See All Slides - tctmd.com

Slides

Presentation CTO 2016

European Registry Update

Presenter: David E. Kandzari, Bradley H. Strauss, Georgios Sianos

February 26, 2016

Presentation CHIP Florida 2016

PCI of High Risk Patients Under Hemodynamic Support: For Whom and with What?

Presenter: Jeffrey W. Moses

April 01, 2016

Presentation TVT 2016

Current Devices for Transcatheter MVR: Summary of Design Feature Similarities and Differences

Presenter: Michael J. Mack

June 16, 2016

Presentation JIM 2016

Can we Bury the GHOST? Practice evolution with BRS

Presenter: Corrado Tamburino

February 10, 2016

Presentation

Occupational Health Risks in Cardiac Catheterization Laboratory Workers

Presenter: Maria Grazia Andreassi

April 13, 2016

Presentation

Treatment, Outcomes of Acute MI Complicated by Shock After Public Reporting Policy Changes in New York

Presenter: James McCabe

July 27, 2016

Presentation TVT 2016

Multimodality Intraprocedural Assessment of the Severity of Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

June 16, 2016

Presentation JIM 2016

Oral antiplatelet therapy in elderly New P2Y12 inhibitors are the right choice

Presenter: Alberto Menozzi

February 11, 2016

Presentation

Antidepressant Use and Risk of CV Outcomes in People Aged 20 to 64

Presenter: Carol Coupland

March 24, 2016

Presentation

CLEAN-TAVI: Effect of a Cerebral Protection Device on Brain Lesions Following TAVR in Patients With Severe Aortic Stenosis

Presenter: S. Haussing

August 11, 2016

Advertisement

Slides

European Registry Update

PCI of High Risk Patients Under Hemodynamic Support: For Whom and with What?

Current Devices for Transcatheter MVR: Summary of Design Feature Similarities and Differences

Can we Bury the GHOST? Practice evolution with BRS

Occupational Health Risks in Cardiac Catheterization Laboratory Workers

Treatment, Outcomes of Acute MI Complicated by Shock After Public Reporting Policy Changes in New York

Multimodality Intraprocedural Assessment of the Severity of Paravalvular Regurgitation After TAVR

Oral antiplatelet therapy in elderly New P2Y12 inhibitors are the right choice

Antidepressant Use and Risk of CV Outcomes in People Aged 20 to 64

CLEAN-TAVI: Effect of a Cerebral Protection Device on Brain Lesions Following TAVR in Patients With Severe Aortic Stenosis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content